Clinical trial NCT04515173: Artificial Intelligence in Mental Illness Diagnosis and Treatment
Official title: Artificial Intelligence for Enhancing the Diagnosis and Treatment of Mental Illness：a Prospective, Randomized Controlled Multicenter Clinical Trail
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Artificial Intelligence
Mental Illness
Lead sponsor: Shanghai Mental Health Center
Sponsor class: OTHER
First posted: 2020-08-17
Enrollment: 4000
Sex: ALL
Minimum age (years): 18
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: To improve the quality of mental health services, we will develop a robot that includes disease screening, diagnosis, treatment, and follow-up. The effectiveness of robots will be verified in a prospective, randomized, multi-center clinical trial. We assume that the robot will reduce the differences in the experience of doctors of different years and will improve mental health care across the country, and improve the uneven distribution of mental health resources through remote resource sharing.

Detailed description: Anxiety disorder is the most common mental disorder in the world. The lifetime prevalence of anxiety disorder in China is as high as 7.6%, but the treatment rate is less than 30%, and the standard treatment rate is only 9.8%. The disease burden is heavy, and it is one of the most serious public health problems in China. Anxiety disorder is a chronic relapsing disease, single drug treatment only 35-50% efficient, psychological treatment as the most international evidence-based foundation and anxiety disorder most commonly used treatment method, can be a single treatment for anxiety disorders or improve the effect of the medication, but because of clinical psychology in China started late, the lack of professionals, unable to meet the huge demand for psychological treatment in our country, therefore, how to develop efficient and standardized anxiety disorders psychotherapy pattern, improve the psychological treatment of acquired, is the key to improve the clinical curative effect of anxiety disorders. Based on the intelligent assisted psychotherapy system based on cognitive behavior and mindfulness developed in the early stage, this research group established the accurate psychotherapy artificial intelligence robot based on evaluation to assist the whole process of standardized psychotherapy for anxiety disorders.

Eligibility criteria: Inclusion Criteria:

* Community high-risk groups and institutional groups.
* According to the ICD-11 diagnostic guidelines of anxiety-related disorders, depression-related disorders, addiction-related disorders, compulsive-related disorders diagnosis,
* age 18-60 years old,
* skilled in the operation of computers or smartphones,
* language, reading ability is normal,
* willing to participate in the project and sign informed consent study.

Exclusion Criteria:

* The symptoms of mental illness are severe and require hospitalization, or the patient is unable to complete the required assessment examination and treatment.
* Those who have a higher risk of self-injury or suicide.
* People with severe physical illness, central system disease, or substance abuse.
* Receive physical therapy at the same time.

Primary outcomes:
measure: System sensitivity
timeFrame: Baseline
measure: System specificity
timeFrame: Baseline
measure: Cure rate
timeFrame: 24 weeks
measure: Recurrence rate
timeFrame: 24 weeks
Secondary outcomes:
measure: Patients' satisfaction
timeFrame: Baseline, 12 weeks, 24 weeks
measure: Clinical global impressions
timeFrame: Baseline, 12 weeks, 24 weeks
measure: Social function
timeFrame: Baseline, 12 weeks, 24 weeks
measure: Doctors' satisfaction
timeFrame: Baseline, 12 weeks, 24 weeks
Other outcomes:
Locations:
Study officials:
affiliation: SMHC
name: Yifeng Xu
role: STUDY_CHAIR
affiliation: SMHC
name: Jianyin QIU
role: STUDY_DIRECTOR
References: